Al Majed For Oud Company announces the execution of a memorandum of understanding with Mr. Othman Abdullah Othman Al-Suwaih Mr. Abdullah Othman Abdullah Al-Suwaih and Mr. Amr Othman Abdullah Al-Suwaih. Limited for a potential acquire of the entire share capital of Al Safa Pharmaceuticals and Medical Supplies Limited Liability Company

Element List	Explanation
Introduction	Al Majed For Oud Company announces the execution of a memorandum of understanding with Mr. Othman Abdullah Othman Al-Suwaih; and Mr. Abdullah Othman Abdullah Al-Suwaih, and Mr. Amr Othman Abdullah Al-Suwaih and to potentially acquire 100% of Al Safa Pharmaceuticals and Medical Supplies Limited Liability Company’s share capital with commercial registration number 1010148073 (the “Proposed Transaction”).
Memorandum Signing Date	2025-12-30 Corresponding to 1447-07-10
Counterparty	Mr. Othman Abdullah Othman Al-Suwaih

Mr. Abdullah Othman Abdullah Al-Suwaih

Mr. Amr Othman Abdullah Al-Suwaih Memorandum Subject To provide Al Majed For Oud Company with the sole and exclusive right to acquire the entire share capital of Al Safa Pharmaceuticals and Medical Supplies Limited Liability Company from Mr. Othman Abdullah Othman Al-Suwaih Mr.Abdullah Othman Abdullah Al-Suwaih and Mr. Amr Othman Abdullah Al-Suwaih. Memorandum Duration The Memorandum of Understanding shall be valid for a period of Six (6) months. And it may be extended upon mutual and written agreement of the Parties. Related Parties There are no related parties Financial Impact The financial impact cannot be determined at this stage, as the Memorandum of Understanding relates to the evaluation of the Proposed Transaction and the conduct of due diligence. Accordingly, the impact of the Proposed Transaction on Al Majed For Oud Company’s financial statements has not yet been determined. Additional Information Al Majed For Oud Company will make any material disclosures related to the Proposed Transaction in due course.

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.